APIs para investigación e impurezas

Applications Anti-inflammatory. Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package References Becker, A., et al.: J. Int. Med. Res., 8, 333 (1980), Child, R.G., et al.: Arzneim.-Forsch., 30, 695 (1980), Bolte, H.F., et al.: Arzneim.-Forsch., 30, 721 (1980).

Please enquire for more information about L-Piperacillin including the price, delivery time and more detailed product information at the technical inquiry form on this page

Atorvastatin is a drug product that is designed for the treatment of dyslipidemia, hypercholesterolemia, and mixed dyslipidemia. It is an impurity in the drug product Atorvastatin EP. Impurity B is a natural metabolite that has been found to have a niche market as an analytical standard for HPLC. The metabolite can be synthesized with high purity and quality standards, which are suitable for use in pharmacopoeia and research and development.

N,N-Dimethyl-3-(1-naphthalenyloxy)-3-(2-thienyl) propanamine tartrate (DMNPA) is a synthetic compound with the molecular formula C14H17NO. DMNPA is used as an analytical reference standard for the quantification of N,N-dimethyl-3-(1-naphthalenyloxy)-3-(2thienyl) propanamine HCl by HPLC. DMNPA has been shown to be a metabolite of the drug product, where it is formed from oxidation of the parent drug.

Stability Hygroscopic Applications Novel application of glucosamine to prepare medical agent for treating vertigo. Found in chitin, in mucoproteins, and in mucopolysaccharides. Antiarthritic. Recent studies show that its chondroprotective activity is related to its antiapoptic properties. References Zupanets, I.A. et al.: Klin. Farmat., 15, 67 (2011); Vajarudal, Y., et al.: Clin. Ther., 3, 336 (1981); Setnikar, I., et al.: Arzneim.-Forsch., 36, 729 (1986);